Makoto Inada

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Tohoku University. Active years: 2004-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Makoto Inada. Retrieved from https://idiyas.com/inventor/makoto-inada-p5iigxw0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 14.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 6(Granted Patents)

Location History:

Tokushima-ken, JP (2004 - 2009)
Osaka, JP (2019)
Tokushima, JP (2006 - 2022)

Company Filing History:

7 out of 846

Otsuka Pharmaceutical Company, Limited

where one patent can have more than one assignee

Years Active: 2004-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11313861 - Method of evaluating hepatic glucose uptake capacity (2022-04-26),

2. 10444229 - Method of measuring insulin resistance with fatty acid combustion, and composition used herein (2019-10-15),

3. 10393730 - Energy malnutrition evaluation for liver disease test subject (2019-08-27),

4. 10228365 - Method for measuring carbohydrate metabolism ability, and composition for use in said method (2019-03-12),

5. 7488466 - Preparation for determining pyrimidine metabolic capacity (2009-02-10),

6. 7018613 - Preparations for evaluating eliminative ability of stomach (2006-03-28),

7. 6797256 - Composition for determining pyrimidine metabolizing activity (2004-09-28),

Title: Makoto Inada: Innovator in Diabetes Research

Introduction

Makoto Inada is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of diabetes research, holding a total of seven patents. His work focuses on innovative methods for evaluating glucose uptake and measuring insulin resistance.

Latest Patents

Inada's latest patents include a method for evaluating hepatic glucose uptake capacity. This invention aims to provide a composition and method for assessing the hepatic glucose uptake capacity of a subject. It also includes a method for determining the stage of pre-onset diabetes using this evaluation method. Another notable patent involves a method for measuring insulin resistance with fatty acid combustion. This invention provides a method for assessing insulin resistance in a test subject using a composition that includes a C-fatty acid labeled with isotopes.

Career Highlights

Throughout his career, Makoto Inada has worked with notable organizations such as Otsuka Pharmaceutical Company and Tohoku University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Inada has collaborated with esteemed colleagues, including Nobuhiro Ikei and Hideji Nonomura. These partnerships have further enriched his research endeavors and innovations.

Conclusion

Makoto Inada's work in diabetes research exemplifies the impact of innovative thinking in the medical field. His patents and collaborations highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.